Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial

Background: Supraglottic airway device (SAD) is a common device use in anaesthesia practice including paediatric patients. Air-Q ILA (Cook gas LLC; Mercury Medical, Clearwater, FL, USA) is the newer first generation of SAD that can use for both primary airway device and an aid for tracheal intuba...

Full description

Saved in:
Bibliographic Details
Main Author: Said, Nirawanti Mohamad
Format: Thesis
Language:English
Published: 2018
Subjects:
Online Access:http://eprints.usm.my/46743/1/Dr.%20Nirawanti%20Mohamad%20Said-24%20pages.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.46743
record_format uketd_dc
spelling my-usm-ep.467432020-07-16T03:32:08Z Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial 2018 Said, Nirawanti Mohamad RD Surgery Background: Supraglottic airway device (SAD) is a common device use in anaesthesia practice including paediatric patients. Air-Q ILA (Cook gas LLC; Mercury Medical, Clearwater, FL, USA) is the newer first generation of SAD that can use for both primary airway device and an aid for tracheal intubation. Available literature demonstrated that this device performed better and equally to the other SAD including second generation of SAD. Ambu® AuraGain™ (Ambu, Ballerup, Denmark) is a newer second generation of SAD which incorporates both integrating gastric port access and intubation capability. The study is conducted to compare the effectiveness between Air- Q and Ambu AuraGain for controlled ventilation in children up to 30kg. Methods: 64 paediatric patients underwent various short surgical procedures were randomly assigned to receive either an Air-Q or Ambu AuraGain. Fibreoptic (FO) grades of laryngeal view were measured as the primary outcome. The secondary outcomes measured were oropharyngeal leak pressure (OLP), number of attempts, time of successful insertion, quality of airway during placement and maintenance of anaesthesia, haemodynamic parameters and complications. Results: Air-Q has more favourable FO grades of view compared to the Ambu AuraGain (P = 0.047). OLP is significantly higher in Air-Q group compared to Ambu AuraGain (19.41 ± 1.19 cm H20 vs 17.56 ± 1.52 cm H20, P value = <0.001). There were no differences in term of number of attempts, time of successful insertion, quality of airway during placement and maintenance of anaesthesia and complications. 2018 Thesis http://eprints.usm.my/46743/ http://eprints.usm.my/46743/1/Dr.%20Nirawanti%20Mohamad%20Said-24%20pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic RD Surgery
spellingShingle RD Surgery
Said, Nirawanti Mohamad
Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
description Background: Supraglottic airway device (SAD) is a common device use in anaesthesia practice including paediatric patients. Air-Q ILA (Cook gas LLC; Mercury Medical, Clearwater, FL, USA) is the newer first generation of SAD that can use for both primary airway device and an aid for tracheal intubation. Available literature demonstrated that this device performed better and equally to the other SAD including second generation of SAD. Ambu® AuraGain™ (Ambu, Ballerup, Denmark) is a newer second generation of SAD which incorporates both integrating gastric port access and intubation capability. The study is conducted to compare the effectiveness between Air- Q and Ambu AuraGain for controlled ventilation in children up to 30kg. Methods: 64 paediatric patients underwent various short surgical procedures were randomly assigned to receive either an Air-Q or Ambu AuraGain. Fibreoptic (FO) grades of laryngeal view were measured as the primary outcome. The secondary outcomes measured were oropharyngeal leak pressure (OLP), number of attempts, time of successful insertion, quality of airway during placement and maintenance of anaesthesia, haemodynamic parameters and complications. Results: Air-Q has more favourable FO grades of view compared to the Ambu AuraGain (P = 0.047). OLP is significantly higher in Air-Q group compared to Ambu AuraGain (19.41 ± 1.19 cm H20 vs 17.56 ± 1.52 cm H20, P value = <0.001). There were no differences in term of number of attempts, time of successful insertion, quality of airway during placement and maintenance of anaesthesia and complications.
format Thesis
qualification_level Master's degree
author Said, Nirawanti Mohamad
author_facet Said, Nirawanti Mohamad
author_sort Said, Nirawanti Mohamad
title Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
title_short Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
title_full Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
title_fullStr Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
title_full_unstemmed Comparing the effectiveness between Air-Q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
title_sort comparing the effectiveness between air-q intubating laryngeal airway and ambu® auragain™ laryngeal mask for controlled ventilation in paediatric patients : a randomized controlled trial
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Perubatan
publishDate 2018
url http://eprints.usm.my/46743/1/Dr.%20Nirawanti%20Mohamad%20Said-24%20pages.pdf
_version_ 1747821721169166336